v3.25.0.1
Additional Information - Condensed Financial Information of the Parent Company (Tables)
12 Months Ended
Dec. 31, 2023
Additional Information - Condensed Financial Information of the Parent Company [Abstract]  
Schedule of Condensed Statements of Operations and Comprehensive Loss

Condensed statements of operations and comprehensive loss:

 

   For the year ended December 31, 
   2021   2022   2023 
   RMB   RMB   RMB   US$ 
Operating expenses:                
Selling and marketing expenses   (9)   
-
    
-
    
-
 
General and administrative expenses   (6,701)   (20,637)   (24,540)   (3,456)
Total operating expenses   (6,710)   (20,637)   (24,540)   (3,456)
Interest income/(expenses), net   311    (20)   146    21 
Change in fair value of warrant liability   
-
    11,219    20,732    2,920 
Equity in loss of subsidiaries, VIEs and subsidiaries of VIEs   (96,058)   (157,586)   (77,289)   (11,242)
Others, net   512    534    502    70 
Net loss   (101,945)   (166,490)   (80,449)   (11,687)
Other comprehensive (loss)/income:                    
Foreign currency translation adjustments   (1,603)   (1,008)   125    18 
Total comprehensive loss attributable to TuanChe Limited’s ordinary shareholders   (103,548)   (167,498)   (80,324)   (11,669)
Schedule of Condensed Balance Sheets

Condensed balance sheets:

 

   As of December 31 
   2022   2023 
   RMB   RMB   US$ 
ASSETS            
Current assets:            
Cash and cash equivalents   57,168    3,004    423 
Prepayment and other current assets   5,712    9,797    1,380 
Receivables due from subsidiaries, VIEs and subsidiaries of VIEs   121,957    135,144    19,035 
Total current assets   184,837    147,945    20,838 
Non-current assets:               
Investments in subsidiaries, VIEs and subsidiaries of VIEs   (53,080)   (113,494)   (15,985)
Total non-current assets   (53,080)   (113,494)   (15,985)
TOTAL ASSETS   131,757    34,451    4,853 
LIABILITIES AND SHAREHOLDERS’ EQUITY               
Current liabilities:               
Other taxes payable   6,643    6,755    951 
Other current liabilities   4,752    1,519    214 
Payables due to subsidiaries, VIEs and subsidiaries of VIEs   2,710    2,741    386 
Total current liabilities   14,105    11,015    1,551 
Non-current liabilities:               
Warrant liability   24,376    3,952    557 
Other non-current liabilities   492    
-
    
-
 
Total non-current liabilities   24,868    3,952    557 
TOTAL LIABILITIES   38,973    14,967    2,108 
SHAREHOLDERS’ EQUITY               
Class A ordinary shares   235    236    33 
Class B ordinary shares   35    35    5 
Treasury stock   (45,886)   (45,886)   (6,463)
Additional paid-in capital   1,296,951    1,306,496    184,016 
Accumulated loss   (1,150,135)   (1,233,106)   (173,679)
Accumulated other comprehensive loss   (8,416)   (8,291)   (1,167)
TOTAL SHAREHOLDERS’ EQUITY   92,784    19,484    2,745 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY   131,757    34,451    4,853 
Schedule of Condensed Statements of Cash Flows

Condensed statements of cash flows:

 

   For the year ended December 31, 
   2021   2022   2023 
   RMB   RMB   RMB   US$ 
Net cash (used in)/generated from operating activities   (10,358)   (22,570)   4,075    574 
Cash flows from investing activities:                    
Cash paid for investments in subsidiaries, VIEs and subsidiaries of VIEs   (38,387)   (56,566)   (59,263)   (8,347)
Cash received from maturity of time deposits   45,674    
-
    
-
    
-
 
Net cash generated from/ (used in) investing activities   7,287    (56,566)   (59,263)   (8,347)
Cash flows from financing activities:                    
Proceeds of offering, net of issuance costs   
-
    93,526    
-
    
-
 
Net cash generated from financing activities   
-
    93,526    
-
    
-
 
Effect of exchange rate changes on cash and cash equivalents   (1,619)   967    1,024    144 
Net (decrease)/increase in cash and cash equivalents   (4,690)   15,357    (54,164)   (7,629)
Cash and cash equivalents at the beginning of year   46,501    41,811    57,168    8,052 
Cash and cash equivalents at the end of year   41,811    57,168    3,004    423